Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

HK Stock Market Move | GOLDEN THROAT (06896) rose more than 10% during the day, with expected annual revenue and profits decreasing by at least 20% year on year.

China Securities Co.,Ltd.: AI computing power-driven cooling structure upgrade, liquid cooling primary side equipment welcomes value reassessment.

HK Stock Market Move | RUIFENG POWER (02025) plunged more than 40% in a single day, with its stock price halving in three trading days. Prior to this, the stock was singled out for its highly concentrated price.
HK Stock Market Move | GOLDEN THROAT (06896) rose more than 10% during the day, with expected annual revenue and profits decreasing by at least 20% year on year.

China Securities Co.,Ltd.: AI computing power-driven cooling structure upgrade, liquid cooling primary side equipment welcomes value reassessment.

HK Stock Market Move | RUIFENG POWER (02025) plunged more than 40% in a single day, with its stock price halving in three trading days. Prior to this, the stock was singled out for its highly concentrated price.

RECOMMEND

“A+H” Team Continues To Expand Hard Technology Firms Accelerate Global Deployment
11/03/2026

Anti‑Stagflation Theme Guides Hong Kong Allocation Institutions Identify Power And Energy Assets As Short‑Term Core
11/03/2026

U.S. Equities Enter “Always‑On” Trading Era Nasdaq Advances Stock Tokenization Framework
11/03/2026


